Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

31 Years of 15%+ Average ROE — Is ABC Arbitrage the Market-Volatility Stock Nobody Talks About?

Most investors have never heard of ABC arbitrage. The Paris-listed group is a specialist proprietary-trading and asset-management firm that makes money from tiny, fleeting price discrepancies across global markets — statistical andMergerarbitrage, rather than directional bets. Its pitch is unusual: it claims 31 consecutive …

Ankur Sharma | 13 August 2026

10x Genomics Raises 2026 Guidance After an 'Extraordinary' Atera Response — Is the Genomics Comeback Finally Here?

On 6 August 2026, 10x Genomics (NASDAQ:TXG) reported second-quarter results and nudged up its full-yearRevenueguidance, crediting what chief executive Serge Saxonov called "the extraordinary customer response" to Atera, its newest spatial-biology platform, launched in April. Headline revenue actually fell year on year, yet the …

Ankur Sharma | 13 August 2026

Skyrizi Hits $5.5 Billion in Quarterly Sales — Can AbbVie Finally Leave the Humira Hangover Behind?

For much of the past three years, AbbVie's story has been dominated by one word: Humira. The world's best-selling drug lost US exclusivity in 2023, and the resultingRevenuedecline — the so-called 'Humira hangover' — has shadowed the stock ever since. AbbVie's second-quarter 2026 results, …

Ankur Sharma | 13 August 2026

Abeona Expands the ZEVASKYN Treatment Network — Is Commercial Gene Therapy Finally Turning Into Real Revenue?

Gene therapy has long promised medical miracles and delivered financial heartache — spectacular science paired with spectacular cash burn. Abeona Therapeutics is trying to buck that pattern. Its ZEVASKYN, a one-time autologous cell-sheet therapy for the devastating skin disease recessive dystrophic epidermolysis bullosa (RDEB), …

Ankur Sharma | 13 August 2026

Abbott Just Had Its Best Day in 24 Years — Is the Healthcare Giant's Growth Engine Back?

When Abbott Laboratories reported second-quarter 2026Earningson 16 July, the market's reaction was emphatic. The shares jumped sharply — press coverage described the move as Abbott's best single day in around 24 years — as the Illinois-based group beat profit expectations and lifted its full-year …

Ankur Sharma | 13 August 2026

Liquidia Beats Revenue Projections, Strengthens Position in Market

Liquidia has recently outperformed sales expectations, providing a significant boost in its competitive stance against United Therapeutics. The company's remarkable sales growth highlights its strong market presence, particularly notable as investors scrutinize the ever-evolving biotech environment. Liquidia's performance is especially critical given the industry's …

Vinay Lochav | 12 August 2026

GENinCode PLC Shares Fall 10.53% as Investors Reassess FDA Progress and Commercial Growth

GENinCode PLC has moved sharply into focus afterLSE:GENI fell 10.53% on 12 August 2026.

Ankur Sharma | 12 August 2026

Kyntra Bio: Could One Major Milestone Turn This Microcap Into a Breakout Trade?

Kyntra Bio, the renamed FibroGen, has slimmed down into a focused cancer developer with roughly $100m of cash and one looming data readout. For patient risk-takers, a single fourth-quarter milestone could redefine the story.

Ankur Sharma | 12 August 2026

Arecor Therapeutics: Could the Biotech Funding Revival Put This Tiny Stock Back in the Spotlight?

Arecor has spent a decade turning formulation science into better medicines. Non-dilutive funding, a marquee insulin-deliveryPartnershipand a pivotal Phase 2 trial now loom. With biotech financing thawing, could this £22m minnow reclaim investor attention?

Ankur Sharma | 12 August 2026

RUA Life Sciences Shares Jump 13.88%: Could Improving Profitability and Structural Heart Value Be Driving Fresh Interest?

RUA Life Sciences PLC LSE:RUA is in focus on12 August 2026 after its shares gained 13.88%, putting the specialist medical-device company among the strongest healthcare movers in the UK small-cap market.

Ankur Sharma | 12 August 2026
Support

Hi! How can we help you today?

Loading…